NIU’s Global Round-up: Direct-selling challenges in China, CBD in Germany, and more

By Stephen Daniells

- Last updated on GMT

© Getty Images / scanrail
© Getty Images / scanrail

Related tags Cbd China microbiome

What’s happened across the Nutra-verse over the past seven days? Stay on top of things with our weekly round-up of key news from across the globe.


CBD’s Novel Food status reiterated by German high courts

A ruling by the North Rhine-Westphalia Senate reinforces a decision by another German court late last year that cannabidiol (CBD) is indeed a novel food.

An unnamed defendant had appealed a ruling by the Düsseldorf Administrative Court, which extended to accusations that the Commission had changed its assessment and they were entitled to at least a transition period to exhaust stocks.

However, the Senate disagreed, arguing that the defendant should have known about the unclear position of CBD and protection of consumers takes precedence over other considerations.

The Senate added that even if the starting material was not novel, there must be evidence of safe consumption for the final product as well to exclude novel food status.

For more on this, please click HERE​.


Amid tough market environment direct-selling firms in China look to new retail channels

With declines reported for the direct-selling industry in China as the regulatory framework tightens and consumers’ perception becomes less favorable, many firms are now adopting new sales models.

Some firms have reportedly turned their focus to cross-border e-commerce (CBEC) and social commerce. 

“The direct-selling industry has been declining in the past few years. The current public discourse surrounding the direct-selling enterprises are not very positive too,”​ said Charles Diao, regulatory manager at US-China Health Products Association.

For more on this, please click HERE​.


Chilean currants may offer microbiome benefits

Intestines probiotics © Getty Images JONGHO SHIN
© Getty Images / JONGHO SHIN

Chilean and Spanish scientists reported that polyphenol-rich Chilean currants (Ribes magellanicum​ and Ribes punctatum​) may boost the levels of gut bacteria linked to anti-inflammatory effects.

According to data from simulated colon experiments, the currants led to increases in Akkermansia muciniphila​ and Faecalibacterium prausnitzii​.

But no increases in Lactobacillus​ spp. and Bifidobacterium​ spp. were reported.

“To the best of our knowledge, this is the first study describing the modulation of gut microbiota and its metabolites by Chilean berries,” ​wrote scientists from the Universidad de Talca (Chile) and Universidad Europea de Madrid (Spain) in Food Research International.

“Our results suggest that polyphenols from ​R. punctatum and ​R. magellanicum may modulate both bacterial metabolism and some selected gut beneficial bacteria under simulated conditions,”​ they wrote.

“Therefore, Chilean currants might be useful as supplements to maintain a healthy colon; however, further in vivo studies are needed to confirm their effect and their mechanisms.”

For more on this story, please click HERE​.

Related news

Related products

show more

Innovate with EpiCor Postbiotic!

Innovate with EpiCor Postbiotic!

Content provided by Cargill | 10-Jun-2024 | White Paper

Upgrade your innovation with EpiCor® Postbiotic! EpiCor® is an innovative, science-backed postbiotic ingredient clinically shown to support immune health....

The solutions to botanical supply chain challenges

The solutions to botanical supply chain challenges

Content provided by Ayana Bio | 05-Jun-2024 | Infographic

Many botanicals continue to face supply chain challenges, from the surging demand for stress-relieving adaptogens and immune-support ingredients to the...



Content provided by BIONAP BIOACTIVE NATURAL PRODUCTS | 30-May-2024 | Product Brochure

Nature's power is a gift, one that BIONAP knows how to use responsibly. From the very beginning of our work to the last detail, Biodiversity is what inspires...

Related suppliers

Follow us


View more